NCT06252857View on ClinicalTrials.gov

Real-world Evaluation of Diagnostic and Treatment Strategies in Low-Risk Basal Cell Carcinoma

RecruitingOBSERVATIONAL
Enrollment

142

Participants

Timeline

Start Date

April 22, 2024

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Basal Cell Carcinoma
Interventions
DRUG

Imiquimod Topical

Topical application of imiquimod (once daily, 5 days a week, during 6 weeks) versus surgical excision.

Trial Locations (1)

6229 HX

RECRUITING

Maastricht UMC+, Maastricht

All Listed Sponsors
lead

Maastricht University Medical Center

OTHER